Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
Truist raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $460 and keeps a Buy rating on the shares. The firm is positive on the launch of Journavx, which is seeing “broad ...
Brewers seek nominations for several community-based awards
MILWAUKEE (WSAW) - Nominations are open now for a series of community recognition programs from the Milwaukee Brewers including the Grand Slam Teacher of the Month, Hometown Champions, presented by ...